Chemours (NYSE:CC) Announces Earnings Results

Chemours (NYSE:CC - Get Free Report) released its quarterly earnings data on Tuesday. The specialty chemicals company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.10 by $0.01, Zacks reports. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.37 billion.

Chemours Stock Down 4.1 %

Shares of Chemours stock traded down $0.71 on Friday, reaching $16.77. The stock had a trading volume of 2,028,076 shares, compared to its average volume of 1,774,895. The company has a 50 day moving average price of $18.09 and a 200 day moving average price of $18.91. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70. Chemours has a 1 year low of $15.10 and a 1 year high of $29.83. The stock has a market capitalization of $2.51 billion, a P/E ratio of 29.42 and a beta of 1.81.

Chemours Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.96%. The ex-dividend date of this dividend is Friday, February 28th. Chemours's payout ratio is currently 175.44%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on CC shares. Morgan Stanley lowered their target price on shares of Chemours from $25.00 to $22.00 and set an "equal weight" rating for the company in a report on Monday, January 13th. Mizuho decreased their price objective on shares of Chemours from $22.00 to $21.00 and set a "neutral" rating for the company in a report on Tuesday, January 7th. Barclays lifted their price objective on shares of Chemours from $21.00 to $23.00 and gave the company an "equal weight" rating in a report on Tuesday, November 5th. BMO Capital Markets decreased their price objective on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a report on Wednesday. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $25.00 target price on shares of Chemours in a research report on Thursday, December 12th. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $23.56.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.